Therapeutic drug monitoring status of four common antibiotics: vancomycin, meropenem, linezolid and teicoplanin-Reference-Cited by-同舟云学术

Therapeutic drug monitoring status of four common antibiotics: vancomycin, meropenem, linezolid and teicoplanin

Published:2022-10-27 Issue:7-8 Volume:82 Page:556-562
ISSN:0036-5513
Container-title:Scandinavian Journal of Clinical and Laboratory Investigation
language:en
Short-container-title:Scandinavian Journal of Clinical and Laboratory Investigation

Author:

Zhou Weiyan¹,Deng Yuhang²,Liu Xiaoxue³,Liu Zhenni²,Huang Chenrong³,Miao Liyan³,Zhang Chuanbao¹

Affiliation:

1. National Center for Clinical Laboratories, Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, PR China

2. National Center for Clinical Laboratories, Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, PR China

3. Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou, PR China

Funder

the Beijing Natural Science Foundation

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365513.2022.2137689

Reference11 articles.

1. How to use vancomycin optimally in neonates: remaining questions

2. A novel reversed-phase high-performance liquid chromatographic assay for the simultaneous determination of imipenem and meropenem in human plasma and its application in TDM